# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-040187
Filing Date
2024-09-12
Accepted
2024-09-12 06:07:46
Documents
92
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | inpha-20240630.htm iXBRL | 6-K | 218735
2 | EX-99.2 | inpha-20240630_d2.htm iXBRL | EX-99.2 | 1139066
| Complete submission text file | 0001628280-24-040187.txt |  | 8168002

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | inpha-20240630.xsd | EX-101.SCH | 100249
4 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | inpha-20240630_cal.xml | EX-101.CAL | 101879
5 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | inpha-20240630_def.xml | EX-101.DEF | 326790
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | inpha-20240630_lab.xml | EX-101.LAB | 719417
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | inpha-20240630_pre.xml | EX-101.PRE | 515842
94 | EXTRACTED XBRL INSTANCE DOCUMENT | inpha-20240630_htm.xml | XML | 1543125

Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 241293821
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)